Aarti Pharmalabs Limited (AARTIPHARM) — Financial Flexibility Index
Aarti Pharmalabs Limited (AARTIPHARM) has a Financial Flexibility Index of 0.06x as of September 2023. Free cash flow of Rs362.80 Million (operating CF Rs362.80 Million minus capex Rs0.00) represents 0% of total liabilities (Rs6.56 Billion). Check Aarti Pharmalabs Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aarti Pharmalabs Limited Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Aarti Pharmalabs Limited across 6 annual periods. For the full cash flow conversion analysis, see AARTIPHARM cash generation efficiency.
Annual Financial Flexibility Index for Aarti Pharmalabs Limited (2020–2025)
Year-by-year free cash flow to debt coverage for Aarti Pharmalabs Limited. Explore AARTIPHARM debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | Rs7.34 Billion | Rs3.32 Billion | Rs9.16 Billion | ▲ +59.1% |
| 2024 | 0.50x | Rs4.15 Billion | Rs2.16 Billion | Rs8.25 Billion | ▼ -9.9% |
| 2023 | 0.56x | Rs3.83 Billion | Rs2.63 Billion | Rs6.86 Billion | ▲ +274.3% |
| 2022 | 0.15x | Rs974.48 Million | Rs-437.04 Million | Rs6.53 Billion | — |
| 2021 | 0.00x | Rs0.00 | Rs0.00 | Rs232.71K | ▲ +100.0% |
| 2020 | -1.00x | Rs-186.75K | Rs-186.75K | Rs186.75K | — |